EATG » Cure

Cure

Targeting HIV: Moving closer to a potential cure

Tri-specific antibody targets and neutralizes 99.5% of HIV-1 virus strains ROCKVILLE, Md., March 13, 2018: A team of researchers at IBBR, led by Dr. Yuxing Li, Associate Professor at the…

CROI 2018: Very early treatment in children limits the HIV reservoir

Very early HIV treatment in infants is feasible and safe and leads to a small reservoir of infected cells, two studies from Botswana and Thailand show. The findings offer hope…

Progress toward a better “shock and kill”?

amfAR-funded scientist Dr. Brad Jones of George Washington University in Washington, DC, has discovered an obstacle to the “shock and kill” strategy for curing HIV that may have implications for…

New way found to defeat HIV latency

SACRAMENTO, Calif., March 7, 2018 — HIV, the virus that causes AIDS, has a secret life. Though anti-retroviral therapy can reduce its numbers, the virus can hide and avoid both…

CROI 2018: No HIV evolution in plasma or lymph nodes on suppressive ART and no impact from further intensification

Two studies with implications for cure research were included in the CROI 2018 press conference on Sunday (March 4), with full presentations on Tuesday (March 6). Both support the idea…

CROI 2018: Experimental antibody plus TLR7 agonist maintains viral suppression in monkeys

Treatment with a broadly neutralising antibody plus an immune-stimulating drug led to long-term viral remission after interrupting antiretroviral therapy in a monkey study, according to data presented at the 25th…

HIV begins to yield secrets of how it hides in cells

Understanding ‘latency’ is a step toward more effective therapies UC San Francisco scientists have uncovered new mechanisms by which HIV hides in infected cells, resting in a latent state that…

HIV – probing for a pathway to a cure

Clinical trial suggests HIV can’t replicate in people on antiretrovirals in what is a key finding for efforts to develop a cure Read the full article here.

HIV i-Base: HIV Treatment Bulletin, 23 February 2018

HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base. The fourth issue of HTB for 2018 is now out. It features highlights from the preliminary programme of…

amfAR renews investment in bioengineering approaches to curing HIV

NEW YORK, Feb. 15, 2018 --- amfAR, The Foundation for AIDS Research, today announced a pair of research grants that renew its support for innovative approaches to HIV cure research.…